William Blair Out Positive On Diplomat Pharmacy, Says CEO Transition Is Another Sign Of The Expansion Of Their Business Model; Believes Co. Can Be Successful Around Better Controlling Specialty Spending, Could Be Positioned Well For Higher Growth